Replies to Post #20310 onMymetics Corp (MYMX)

Replies to #20310 on Mymetics Corp (MYMX)

09/24/20 11:55 AM

#20328 RE: Staypositive1 #20310

WTH is he doing LOL

As part of privately-owned and independent family business JRS, J. RETTENMAIER & Söhne Group, Celonic’s history is a success story.

https://www.jrs.eu/jrs_en/jrs-the-company/jrs-history/

Work Harder

09/24/20 1:12 PM

#20338 RE: Staypositive1 #20310

Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine

https://www.firstwordpharma.com/node/1744520?tsid=33

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156871099

Work Harder

09/24/20 1:37 PM

#20339 RE: Staypositive1 #20310

Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for Coronavirus

https://www.biospace.com/article/releases/airway-therapeutics-and-celonic-group-collaborate-to-produce-at-100-as-promising-new-candidate-for-coronavirus/

Marc Salzberg, MD
President & CEO

He spent several years at Roche’s headquarters in Basel, Switzerland as well as its affiliate in Toronto, Canada. As Head of Clinical Cancer Research at the Basel University, he co-founded and managed a clinical research network in Switzerland (CCRC).

During his career, Marc has successfully managed the growth and acquisition of two contract research organizations benefitting shareholders. He was a founder and President of Pharma Brains, a European boutique CRO, which has been acquired by Medpace, a US based global CRO, after 10 years of successful growth under his leadership. He then served as Vice President of Medical Affairs at Medpace.

Marc earned his Medical Doctorate degree from the University of Basel, Switzerland. His medical training and practice include pediatrics/ neonatology and oncology.

Michael Hellerstein
Vice President Regulatory Affairs & Quality

Mr. Hellerstein serves as Vice President of Regulatory and Quality at Airway Therapeutics. He has more than 20 years of experience in the life science industry combining a focus on regulatory and quality with broad experience across multiple disciplines of biotech product development. Trained as a molecular biologist, Mr. Hellerstein initially worked in drug discovery and then transitioned into quality, regulatory, and management roles. He worked for 15 years at GeoVax, where he designed and implemented the systems needed to advance vaccines from discovery through clinical trials and his responsibilities grew from method development lead to head of regulatory affairs, quality assurance and control, project management, outsourcing, and government contracting. He has also held positions at Cell Signaling Technology, Pfizer, Blue Sky Biotech, and Kiel Laboratories. Mr. Hellerstein graduated from Harvard University in 1999.

https://www.airwaytherapeutics.com/about-us/

Small world

LOL

Work Harder

09/24/20 7:08 PM

#20358 RE: Staypositive1 #20310

Ole Luc popped in did he

He should say hi to Amy for us

LOL

So, ole Laurent Galibert was

Senior Staff Scientist

2005 - 2008

Merck Serono SA

That explains a lot

Immediately prior to joining Addex Dr. Galibert was senior staff scientist at Merck Serono. From 1996-2005 he held successive research positions at Immunex Corp. (acquired by Amgen Inc.) and Amgen, where he cloned the receptor activator of nuclear factor kappa B ligand (RANKL) and co-authored the initial patent leading to the development of Amgen's denosumab, a monoclonal antibody against RANKL, which is in Phase III development for postmenopausal osteoporosis and in clinical development for other indications. From 1991-1995 Dr. Galibert was a PhD fellow at Schering-Plough.

https://www.researchgate.net/scientific-contributions/38272122_Laurent_Galibert

Laurent Galibert's research while affiliated with Amgen and other places

:}

Work Harder

09/25/20 10:31 AM

#20364 RE: Staypositive1 #20310

Jack Carter honored

https://www.chron.com/neighborhood/bellaire/news/article/Jack-Carter-honored-9840287.php

Technology Transfer Fund

DOD baby

I really like our Baylor Gal

LOL